IBM NYSE Week ended 24 Jul 2026

Weekly Investor Report

International Business Machines · Technology · Information Technology Services

Open interactive chart View report data Download investor PDF
Latest close 214.2 USD
0.7% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -17.4% below the Trend Line and sits at 11.3% of its 52-week range. The latest completed week returned 0.7%, after a -21.1% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is neither clearly cheap nor expensive. Options positioning is bullish with 40/100 conviction, while the latest news-sentiment score is 53/100. Near-term considerations: earnings are due in 84d.

Setup score 27 out of 100
Latest Close 214.2 USD 24 Jul 2026
1W Return 0.7% latest completed week
4W Return -21.1% short-term follow-through
12W Return -7.1% quarterly tape
Trend Breadth 44.2% 23 of 52 weeks active
Volume Ratio 1.2x vs 13-week average
What is working
  • Activity pressure is positive on the latest completed week.
  • Next-week expectancy is positive at 58.44% based on similar historical setup states.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 0.7% Latest completed week; four-week move -21.1%. Indicator stack 24/52 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 58.44% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Bullish 40/100 conviction; expected move 6.8%. News sentiment 53/100 18 relevant articles in the latest sentiment read. Event risk 84d Next report is scheduled for 21 Oct 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -17.4% below the Trend Line and sits at 11.3% of its 52-week range. The latest completed week returned 0.7%, after a -21.1% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.2x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.3612-week average 0.16

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure9/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.36Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers66 reversal markers

No recent accumulation markers. 6 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -21.1% over four weeks, -7.1% over 12 weeks, and -15.4% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W0.7%
4W-21.1%
12W-7.1%
26W-25.8%
52W-15.4%
Active trend streak0 weeks
Active weeks in one year23
Trend breadth44.2%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.38Latest activity-pressure read.
Pressure change-53.7%Four-week change in activity pressure.
Leadership-25.66Latest relative-leadership reading.
RS change-304.4%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 97% Model confidence 97%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength30/100Blend of value, momentum, and quality. Underlying universe rank 71; rank 1 is best.
Value24/100Relative valuation strength. Underlying universe rank 77; rank 1 is best.
Quality92/100Profitability and accounting quality. Underlying universe rank 9; rank 1 is best.
Momentum23/100Medium-term price momentum. Underlying universe rank 78; rank 1 is best.
Growth88/100Revenue and earnings growth. Underlying universe rank 13; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
18.8x
Price divided by trailing earnings.
Price / sales
2.9x
Market value relative to trailing revenue.
EV / EBITDA
16.0x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
6.6%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
58.4%
Gross profit retained from each unit of revenue.
Operating margin
17.9%
Operating profit retained from revenue.
Free-cash-flow margin
24.9%
Free cash flow generated from revenue.
Return on invested capital
10.0%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
7.9%
Latest one-year revenue growth.
EPS growth
83.9%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
16.4%
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
3.1%
Cash dividends relative to market value.
Buyback yield
0.2%
Net share repurchases relative to market value.
Shareholder yield
3.3%
Dividend yield plus net buyback yield.
Net debt / EBITDA
3.6x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

IBM shows bullish options pressure with a 40/100 conviction score, put-call volume ratio of 0.45, expected move of 6.8%, and Sharemaestro trend signal inactive.

Conviction40/100
Expected move6.8%
Put/call volume0.45
Pressure42
Speculation42
Volatility67
Trend agreement24
Open options detail
Insider activity15 / 5

15 acquisitions and 5 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment53/100

Weighted news tone is neutral across 18 relevant articles.

6 positive · 8 neutral · 4 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings84dNext report is scheduled for 21 Oct 2026; event risk rises as the date approaches.
Options expected move6.8%Nearest-chain priced movement where available.
52-week drawdown-35.6%Distance below the 52-week high.
13-week volatility10.7%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher10 of 2616 weeks finished lower.
Best week+17.3%Week of 29 May.
Worst week-26.0%Week of 17 Jul.
Latest week+0.7%Week of 24 Jul.

Shape of recent returns

Strong gains8
Modest gains2
Flat weeks0
Modest losses6
Sharp losses10
Recent vol10.7%13-week weekly-return volatility.
Base vol6.7%52-week weekly-return volatility.
Up/down split25/27Count of positive and negative weeks in the 52-week window.
Average skew4.7% / -4.5%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape31/100

Trend, activity pressure, participation, and risk combine to a 31/100 tape read.

 Indicator analysis22/100

Latest 12-week confirmation: trend 0/12, activity pressure 9/12, relative leadership 0/12.

Activity pressure 0.36; 6 reversal markers Next-Week ExpectancyPositive 58.44%

Next-week expectancy is positive with a 58.44% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors42/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 40 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options48/100

IBM shows bullish options pressure with a 40/100 conviction score, put-call volume ratio of 0.45, expected move of 6.8%, and Sharemaestro trend signal inactive.

Bullish · Call-side pressure · Expected move 6.8% Sentiment53/100

Weighted news tone is neutral across 18 relevant articles.

International Business Machines Corporation $IBM Shares Sold by Altshuler Shaham Ltd Insiders15 / 5

15 acquisitions and 5 disposals in the latest 180-day insider tape.

 Earnings84d

Next report is scheduled for 21 Oct 2026; event risk rises as the date approaches.

 Research flow2 items

0 recent research articles and 2 Market Watch posts are available.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 2026214.2 USD0.7%259.2 USD216.8 USD0.38-25.6662.0MOff
17 Jul 2026212.7 USD-26.0%262.1 USD216.3 USD0.67-27.02137.7MOff
10 Jul 2026287.6 USD-0.7%264.9 USD215.7 USD0.70-3.6137.7MOff
3 Jul 2026289.5 USD6.6%265.5 USD214.6 USD0.67-1.9526.8MOff
26 Jun 2026271.6 USD9.0%266.0 USD213.6 USD0.81-6.3451.7MOff
19 Jun 2026249.1 USD-8.5%267.1 USD212.6 USD0.94-16.5234.3MOff
12 Jun 2026272.2 USD-4.4%268.6 USD211.7 USD1.00-8.5134.6MOff
5 Jun 2026284.8 USD-4.4%269.6 USD210.8 USD0.62-4.1486.1MOff
29 May 2026297.8 USD17.3%270.1 USD209.8 USD0.05-2.5559.4MOff
22 May 2026253.8 USD15.8%270.2 USD208.6 USD-0.51-15.8961.5MOff
15 May 2026219.3 USD-4.6%271.8 USD207.7 USD-0.80-27.0433.1MOff
8 May 2026229.8 USD-0.3%273.7 USD207.1 USD-0.78-23.9326.7MOff
1 May 2026230.5 USD0.1%275.2 USD206.3 USD-0.81-22.3429.5MOff
24 Apr 2026230.3 USD-8.5%276.9 USD205.6 USD-1.01-22.0655.0MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.